Table 3 Clinical outcomes evaluation after 1 year’s follow-up
From: Baseline elevated Lp-PLA2 is associated with increased risk for re-stenosis after stent placement
Variables | Normal Lp-PLA2 (n = 196) | Elevated Lp-PLA2 (n = 130) | P value |
|---|---|---|---|
Cardiovascular related death (%) | 6 (3.1) | 3 (2.3) | 0.138 |
Nonfatal MI (%) | 5 (2.6) | 3 (2.3) | 0.216 |
Nonfatal Stroke (%) | 6 (3.1) | 3 (2.3) | 0.138 |
Re-stenosis (%) | 9 (4.6) | 11 (8.5) | 0.047 |
Total (%) | 26 (13.3) | 20 (15.4) | 0.172 |